Walker H. Busby

5.4k citations

67 papers · 4.6k indexed · 1 hit paper · h-index 40

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Growth Hormone and Insulin-like Growth Factors
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism

Papers in

Endocrinology, Diabetes and Metabolism 42
- Growth Hormone and Insulin-like Growth Factors 38
Immunology and Allergy 7
- Cell Adhesion Molecules Research 7

Co-authors: David R. Clemmons ROBERT G. ELGIN David K. Snyder Robert H. McCusker Gabriella Wright Taek‐Jeong Nam Jane B. Clarke John S. Kizer
Journals: Endocrinology (19 papers)Journal of Biological Chemistry (12 papers)The Journal of Clinical Endocrinology & Metabolism (4 papers)Journal of Cellular Biochemistry (2 papers)Molecular Endocrinology (2 papers)
Partner nations: United States France Russia

In The Last Decade

Walker H. Busby

64 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. 1987 · 590 citations

Peers

Countries citing papers authored by Walker H. Busby

Since Specialization

Citations

This map shows the geographic impact of Walker H. Busby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walker H. Busby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walker H. Busby more than expected).

Fields of papers citing papers by Walker H. Busby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walker H. Busby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walker H. Busby. The network helps show where Walker H. Busby may publish in the future.

Co-authors

The 25 scholars most cited alongside Walker H. Busby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Walker H. Busby Line = papers co-authored together Walker H. Busby links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigs Atherosclerosis ·L.A. Maile, Walker H. Busby, Gang Xi, Rowan Thomas Drinkwater, W. L. Flowers, Josef Ritz, 裕明谷藤, Kara R Stewart, Elizabeth P. Merricks, Timothy C. Nichols, Dwight A. Bellinger, David R. Clemmons	2017	9
2	Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet PLoS ONE ·Timothy C. Nichols, Elizabeth P. Merricks, Dwight A. Bellinger, Robin A. Raymer, Jing Yu, Chengyiran Wei, Gary G. Koch, Walker H. Busby, David R. Clemmons	2015	8
3	Insulin-like Growth Factor-I-stimulated Insulin Receptor Substrate-1 Negatively Regulates Src Homology 2 Domain-containing Protein-tyrosine Phosphatase Substrate-1 Function in Vascular Smooth Muscle Cells Journal of Biological Chemistry ·Yashwanth Radhakrishnan, Walker H. Busby, Xinchun Shen, Laura A. Maile, David R. Clemmons	2010	21
4	Modulation of integrin antagonist signaling by ligand binding of the heparin‐binding domain of vitronectin to the αVβ3 integrin Journal of Cellular Biochemistry ·Laura A. Maile, Josalen Gondrez, Walker H. Busby, И С Новиков, Umadevi Veluvolu, David R. Clemmons	2008	16
5	Recombinant, Nonglycosylated Human Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) Is Degraded Preferentially after Administration to Type II Diabetics, Resulting in Increased Endogenous Glycosylated IGFBP-3 The Journal of Clinical Endocrinology & Metabolism ·David R. Clemmons, 陈亚伟, Walker H. Busby	2005	7
6	Inhibition of insulin‐like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin‐like growth factor 1 and is associated with improved osteoarthritis Arthritis & Rheumatism ·David R. Clemmons, Walker H. Busby, H LAHBABI, Duane R. Schultz, David S. Howell, Roy D. Altman, Robert W. Karr	2002	46
7	Tissue Transglutaminase Facilitates the Polymerization of Insulin-like Growth Factor-binding Protein-1 (IGFBP-1) and Leads to Loss of IGFBP-1's Ability to Inhibit Insulin-like Growth Factor-I-stimulated Protein Synthesis Journal of Biological Chemistry ·Keiji Sakai, Walker H. Busby, Jane B. Clarke, David R. Clemmons	2001	40
8	The Complement Component C1s Is the Protease That Accounts for Cleavage of Insulin-like Growth Factor-binding Protein-5 in Fibroblast Medium Journal of Biological Chemistry ·Walker H. Busby, Taek‐Jeong Nam, Kulwinder Kumar Vohra, Christine E. Smith, Michael P. Jennings, David R. Clemmons	2000	67
9	Binding of Insulin-like Growth Factor (IGF)–Binding Protein-5 to Smooth-Muscle Cell Extracellular Matrix Is a Major Determinant of the Cellular Response to IGF-I Molecular Biology of the Cell ·Wali Ullah Baloch, Catherine Rees, Jane B. Clarke, Walker H. Busby, David R. Clemmons	1998	61
10	A Protease-Resistant Form of Insulin-Like Growth Factor (IGF) Binding Protein 4 Inhibits IGF-1 Actions¹ Endocrinology ·Catherine Rees, David R. Clemmons, Siti Qomariyah, Jane B. Clarke, Walker H. Busby	1998	39
11	Role of insulin-like growth factor binding proteins in the control of IGF actions PubMed ·David R. Clemmons, Walker H. Busby, T Arai, Taek‐Jeong Nam, Jane B. Clarke, John I. Jones, Muhammad Iqbal Ardah	1995	65
12	Proteolytic Cleavage of Insulin-like Growth Factor Binding Protein 4 (IGFBP-4) Journal of Biological Chemistry ·Steven D. Chernausek, Christine E. Smith, Kevin L. Duffin, Walker H. Busby, Gabriella Wright, David R. Clemmons	1995	74
13	Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology ·Taek‐Jeong Nam, Walker H. Busby, D R Clemmons	1994	69
14	Role of Insulin‐like Growth Factor Binding Proteins in Modifying IGF Actions^a Annals of the New York Academy of Sciences ·David R. Clemmons, John I. Jones, Walker H. Busby, Gabriella Wright	1993	73
15	Cloning and sequence determination of bovine insulin‐like growth factor binding protein‐2 (IGFBP‐2): Comparison of its structral and functional properties with IGFBP‐1 Journal of Cellular Biochemistry ·Walker H. Busby, Robert H. McCusker, David R. Clemmons, Maureen Bourner, Cristian Fabricio Moreno Proaño, Gwen G. Krivi	1992	101
16	Three Distinct Forms of Insulin-Like Growth Factor Binding Proteins are Released by Decidual Cells in Culture* Endocrinology ·David R. Clemmons, Kathryn M. Thrailkill, Bruno Azeredo de França, Walker H. Busby	1990	49
17	Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. Journal of Clinical Investigation ·M Leka'a, David R. Clemmons, Walker H. Busby, Stuart Handwerger	1990	58
18	Purified Preparations of the Amniotic Fluid-Derived Insulin-Like Growth Factor-Binding Protein Contain Multimeric Forms that Are Biologically Active* Endocrinology ·Walker H. Busby, Paul Hossenlopp, M Binoux, David R. Clemmons	1989	48
19	Cloning, characterization, and expression of a human insulin-like growth factor binding protein Biochemical and Biophysical Research Communications ·Michael Brewer, Gary L. Stetler, Charles H. Squires, Robert C. Thompson, Walker H. Busby, David R. Clemmons	1988	217
20	Radioimmunoassay of a 26,000-Dalton Plasma Insulin-Like Growth Factor-Binding Protein: Control by Nutritional Variables* The Journal of Clinical Endocrinology & Metabolism ·Walker H. Busby, David K. Snyder, David R. Clemmons	1988	203

About Walker H. Busby

Walker H. Busby is a scholar working on Endocrinology, Diabetes and Metabolism, Immunology and Allergy, Cancer Research, Cell Biology and Molecular Biology, having authored 67 papers that have together received 4.6k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (38 papers), Metabolism, Diabetes, and Cancer (13 papers), Cell Adhesion Molecules Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Lipid metabolism and disorders (5 papers), Protease and Inhibitor Mechanisms (5 papers), Neuropeptides and Animal Physiology (5 papers) and TGF-β signaling in diseases (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.3k citations), Cancer Research (964 citations), Molecular Biology (2.3k citations), Genetics (736 citations) and Immunology and Allergy (155 citations). Walker H. Busby has collaborated with scholars based in United States, France and Russia. Frequent co-authors include David R. Clemmons, ROBERT G. ELGIN, David K. Snyder, Robert H. McCusker, Gabriella Wright, Taek‐Jeong Nam, Jane B. Clarke, David R. Clemmons, John S. Kizer and William W. Youngblood. Their work appears in journals such as Endocrinology, Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism, Journal of Cellular Biochemistry and Molecular Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact